title: Overcoming barriers to adult immunization.
abstract: The herpes zoster vaccine has proven to reduce the incidence of herpes zoster and postherpetic neuralgia, a debilitating condition that can remain for years after zoster rash has resolved. However, few eligible adults have received the vaccine. Findings from survey-based studies on patient uptake of influenza and pneumococcal polysaccharide vaccines suggest that physician recommendations and standing orders can increase vaccine uptake. However, certain barriers unique to zoster vaccination (eg, reimbursement concerns) will need to be addressed.
authors: Section of Infectious Diseases, Wake Forest University, Winston-Salem, NC 27157-1042, USA. khigh@wfubmc.edu
authors: Kevin P
authors: KP
authors: High
mesh_terms: D000328:Adult; D000368:Aged; D006297:Health Services Accessibility; D006562:Herpes Zoster / Q000453:epidemiology* / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D010342:Patient Acceptance of Health Care
chemical_list: D053061:Herpes Zoster Vaccine